{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:14:18Z","timestamp":1793150058433,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T00:00:00Z","timestamp":1442620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40257-015-0155-3","type":"journal-article","created":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T08:58:51Z","timestamp":1442653131000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype"],"prefix":"10.1007","volume":"17","author":[{"given":"Kyle T.","family":"Amber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romi","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,19]]},"reference":[{"issue":"8","key":"155_CR1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ajh.23756","volume":"89","author":"RA Wilcox","year":"2014","unstructured":"Wilcox RA. Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89(8):837\u201351.","journal-title":"Am J Hematol"},{"issue":"10","key":"155_CR2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768\u201385.","journal-title":"Blood"},{"issue":"5","key":"155_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","volume":"12","author":"LD Wilson","year":"2012","unstructured":"Wilson LD, Hinds GA, Yu JB. Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk. 2012;12(5):291\u20136.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"155_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","volume":"40","author":"HS Zackheim","year":"1999","unstructured":"Zackheim HS, Amin S, Kashani-Sabet M, McMillan A. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol. 1999;40(3):418\u201325.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"155_CR5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1747.2000.00011.x","volume":"115","author":"L Vakeva","year":"2000","unstructured":"Vakeva L, Pukkala E, Ranki A. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol. 2000;115(1):62\u20135.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"155_CR6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archderm.135.11.1381","volume":"135","author":"JJ Scarisbrick","year":"1999","unstructured":"Scarisbrick JJ, Child FJ, Evans AV, Fraser-Andrews EA, Spittle M, Russell-Jones R. Secondary malignant neoplasms in 71 patients with Sezary syndrome. Arch Dermatol. 1999;135(11):1381\u20135.","journal-title":"Arch Dermatol"},{"issue":"8","key":"155_CR7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/1097-0142(19890415)63:8<1612::AID-CNCR2820630828>3.0.CO;2-C","volume":"63","author":"AF Kantor","year":"1989","unstructured":"Kantor AF, Curtis RE, Vonderheid EC, van Scott EJ, Fraumeni JF Jr. Risk of second malignancy after cutaneous T-cell lymphoma. Cancer. 1989;63(8):1612\u20135.","journal-title":"Cancer"},{"issue":"1","key":"155_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.143.1.45","volume":"143","author":"KP Huang","year":"2007","unstructured":"Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Arch Dermatol. 2007;143(1):45\u201350.","journal-title":"Arch Dermatol"},{"issue":"4","key":"155_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2340\/00015555-1496","volume":"93","author":"E Hodak","year":"2013","unstructured":"Hodak E, Lessin S, Friedland R, Freud T, David M, Pavlovsky L, et al. New insights into associated co-morbidities in patients with cutaneous T-cell lymphoma (mycosis fungoides). Acta Derm Venereol. 2013;93(4):451\u20135.","journal-title":"Acta Derm Venereol."},{"issue":"2","key":"155_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3816\/CLM.2008.n.011","volume":"8","author":"I Brownell","year":"2008","unstructured":"Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic M. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma. 2008;8(2):100\u20135.","journal-title":"Clin Lymphoma Myeloma."},{"issue":"2 Pt 1","key":"155_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0190-9622(94)70017-6","volume":"30","author":"BR Smoller","year":"1994","unstructured":"Smoller BR, Marcus R. Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoides. J Am Acad Dermatol. 1994;30(2 Pt 1):201\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"155_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/CDLI.6.1.79-84.1999","volume":"6","author":"BN Lee","year":"1999","unstructured":"Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JM. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol. 1999;6(1):79\u201384.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"19","key":"155_CR13","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","volume":"17","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Merlino G. The two faces of interferon-gamma in cancer. Clin Cancer Res. 2011;17(19):6118\u201324.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"155_CR14","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","volume":"118","author":"P Quaglino","year":"2012","unstructured":"Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Alfonso Lombardo G, Rupoli S, et al. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Cancer. 2012;118(23):5830\u20139.","journal-title":"Cancer"},{"issue":"4","key":"155_CR15","first-page":"22369","volume":"20","author":"WM Leon","year":"2014","unstructured":"Leon WM, Aw CW, Tran KB. Lymphomatoid papulosis and recurrent transitional cell carcinoma of the bladder: a paraneoplastic association. Dermatol Online J. 2014;20(4):22369.","journal-title":"Dermatol Online J"},{"issue":"3","key":"155_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annepidem.2007.10.005","volume":"18","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi AK, Mbulaiteye SM, Engels EA. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol. 2008;18(3):230\u20134.","journal-title":"Ann Epidemiol"},{"issue":"3","key":"155_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archderm.144.3.413","volume":"144","author":"GM Dores","year":"2008","unstructured":"Dores GM, Curtis RE, Anderson WF, Demierre MF. Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States. Arch Dermatol. 2008;144(3):413\u20134.","journal-title":"Arch Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-015-0155-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0155-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T13:45:10Z","timestamp":1599572710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-015-0155-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,19]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1007\/s40257-015-0155-3","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,19]]}}}